Back To: Home



June 6-7, 2013
European Lab Automation - Hamburg, Germany

June 12-15, 2013

More Events
Name:
Company:
Email:
 
 
 
PerkinElmer

NextGen finalizes diagnostics subsidiary
April 2012
SHARING OPTIONS:

LONDON—NextGen Group PLC recently announced that the establishment of its new diagnostics subsidiary company, NextGen Sciences Dx Inc., has been completed. The new company, which is located in Boston, will focus on the discovery of biomarkers that can aid in the development of tests for central nervous system disorders such as Parkinson’s disease, dementia and traumatic brain injury. The diagnostic projects the company is currently working on will make it possible for patients to be tested both for the diseases themselves, for changes in their condition and to determine whether drugs that are currently in use or being studied will be effective in treating the disorders. NextGen expects that progress will be made within the next six months on the filing of intellectual property.

Back

cISBIO

Tecan


Beckman

R&D Systems

Singulex

ISSCR
CONTACT US
Drug Discovery News
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2013 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.